66,40 €*
Versandkostenfrei per Post / DHL
Lieferzeit 1-2 Wochen
Richard Warren, MBChB, MRCP, PhD, is a Clinical Senior
Lecturer and Honorary Consultant Dermatologist. He graduated from Liverpool University
with a first class honours degree in Pharmacology and gained his Medical
degree, with honours, one year later. He was awarded The J Hill Abram prize ¿
highest mark in Medicine; and the Reginald Dora Goodrick prize ¿ highest mark
in Surgery. His work in Dermatology has focused on: pharmacogenetics (forming
the basis of his PhD thesis), the genetic susceptibility to psoriasis and more
recently biological therapies and their use in the treatment of psoriasis. For
his work into the pharmacogenetics of methotrexate he has received national and
international awards from the British Association of Dermatologists (BAD) and
American Academy of Dermatology. He is widely published in the field of
dermatology with numerous abstracts, papers and book contributions including
The Lancet, Nature Genetics, and The Journal of Investigative Dermatology. He
is currently the EU Editor in Chief for the journal Dermatology and Therapy. He
has been an invited plenary speaker at major national and international dermatology
meetings and is a member of The International Psoriasis Council. He currently
chairs the BAD guideline group for methotrexate and is a member of the BAD
biologics committee and research subcommittee. In 2012, he was the expert panel
member on the National Institute for Health and Clinical Excellence guideline
group for psoriasis. He co-lead one of the two workstreams involved in the
recent (2013) successful funding from the Medical Research Council stratified
medicine grant (value £7 million) ¿ Psoriasis Optimisation of Relevant Therapies
(PSORT). He coestablished a clinic for patients with severe psoriasis and
psoriatic arthritis in 2010 with Dr Hector Chinoy, which has received wide
acclaim and is used as a national exemplar.
Alan Menter, MD, was born in England and is a graduate of
the Medical School of the University of Witwatersrand, South Africa. He
completed his dermatology residency at Pretoria General Hospital at the
University of Pretoria, also in South Africa, and two fellowships in London at
Guy's Hospital and St John's Hospital for Diseases of the Skin. A fellowship with
the University of Texas Southwestern Medical Center in Dallas brought Menter to
the United States. Since then, he has held several positions within the UT and
Baylor University Dallas systems. In 1992, he was appointed Chairman of the
Division of Dermatology at Baylor University Medical Center and still holds
that position. In 2007, he was appointed Director of the Baylor Research Center
and in 2010, Program Director of the newly formed Dermatology Residency Program
at Baylor University Medical Center.
psoriatic disease research. In 1994, he co-authored the first gene discovery
for psoriasis, published in Science in 1994. His research on psoriasis has
examined everything from ultraviolet phototherapy and biologic therapy to the mapping
of genetic patterns to predict if a person is at risk of developing psoriasis
pharmacogenomics. In August 2004, Dr Menter helped found the International
Psoriasis Council to raise international awareness of psoriasis as a serious
autoimmune disease that can significantly impact quality of life. His clinical
practice includes more than 1600 patients on systemic and biologic therapy.Dr Menter held the position of clinical director of the
National Psoriasis Foundation Gene Bank from 1996 to 2002. His resume lists
some 300+ articles, four books and 19 book chapters. He serves as a member of
the editorial board for several medical journals, including the Journal of
Clinical Dermatology and Clinical and Experimental Dermatology. He is chair of research
for Dermatology at Baylor Research Institute, as well as clinical professor of
dermatology at the University of Texas Southwestern Medical School in Dallas
and professor at Texas A&M Health Science Center, College of Medicine. Dr
Menter has been listed in the Best Doctors in America since 1994 and Whös Who
in Medicine and Healthcare since 1996. He also represented the South African
National Rugby team, the Springboks, in 1968. In 2013, Dr Menter received the
Lifetime Achievement Award from the National Psoriasis Foundation. In March
2015, he received the Dermatology Foundation annual Clark W. Finnerud award at
the American Academy of Dermatology 2015 meeting in San Francisco.
Concise pocket book designed to support physicians, rheumatologists, and dermatologists in their day-to-day practice
Written by leading thought leaders and developed using the latest clinical evidence and guidelines
High quality full-color supportive illustrations, tables, and graphs enable complicated concepts to be made clear to readers with different levels of background understanding
Includes supplementary material: [...]
| Erscheinungsjahr: | 2016 |
|---|---|
| Fachbereich: | Andere Fachgebiete |
| Genre: | Medizin |
| Rubrik: | Wissenschaften |
| Medium: | Taschenbuch |
| Seiten: | 128 |
| Inhalt: |
xi
116 S. 3 s/w Illustr. 7 farbige Illustr. 7 s/w Tab. 7 farbige Tab. 116 p. 10 illus. 7 illus. in color. |
| ISBN-13: | 9783319182261 |
| ISBN-10: | 3319182269 |
| Sprache: | Englisch |
| Herstellernummer: | 978-3-319-18226-1 |
| Ausstattung / Beilage: | Paperback |
| Einband: | Kartoniert / Broschiert |
| Redaktion: |
Menter, Alan
Warren, Richard |
| Herausgeber: | Richard Warren/Alan Menter |
| Auflage: | 1st ed. 2016 |
| Hersteller: |
Springer International Publishing
Springer International Publishing AG |
| Maße: | 203 x 127 x 8 mm |
| Von/Mit: | Alan Menter (u. a.) |
| Erscheinungsdatum: | 29.01.2016 |
| Gewicht: | 0,147 kg |
Richard Warren, MBChB, MRCP, PhD, is a Clinical Senior
Lecturer and Honorary Consultant Dermatologist. He graduated from Liverpool University
with a first class honours degree in Pharmacology and gained his Medical
degree, with honours, one year later. He was awarded The J Hill Abram prize ¿
highest mark in Medicine; and the Reginald Dora Goodrick prize ¿ highest mark
in Surgery. His work in Dermatology has focused on: pharmacogenetics (forming
the basis of his PhD thesis), the genetic susceptibility to psoriasis and more
recently biological therapies and their use in the treatment of psoriasis. For
his work into the pharmacogenetics of methotrexate he has received national and
international awards from the British Association of Dermatologists (BAD) and
American Academy of Dermatology. He is widely published in the field of
dermatology with numerous abstracts, papers and book contributions including
The Lancet, Nature Genetics, and The Journal of Investigative Dermatology. He
is currently the EU Editor in Chief for the journal Dermatology and Therapy. He
has been an invited plenary speaker at major national and international dermatology
meetings and is a member of The International Psoriasis Council. He currently
chairs the BAD guideline group for methotrexate and is a member of the BAD
biologics committee and research subcommittee. In 2012, he was the expert panel
member on the National Institute for Health and Clinical Excellence guideline
group for psoriasis. He co-lead one of the two workstreams involved in the
recent (2013) successful funding from the Medical Research Council stratified
medicine grant (value £7 million) ¿ Psoriasis Optimisation of Relevant Therapies
(PSORT). He coestablished a clinic for patients with severe psoriasis and
psoriatic arthritis in 2010 with Dr Hector Chinoy, which has received wide
acclaim and is used as a national exemplar.
Alan Menter, MD, was born in England and is a graduate of
the Medical School of the University of Witwatersrand, South Africa. He
completed his dermatology residency at Pretoria General Hospital at the
University of Pretoria, also in South Africa, and two fellowships in London at
Guy's Hospital and St John's Hospital for Diseases of the Skin. A fellowship with
the University of Texas Southwestern Medical Center in Dallas brought Menter to
the United States. Since then, he has held several positions within the UT and
Baylor University Dallas systems. In 1992, he was appointed Chairman of the
Division of Dermatology at Baylor University Medical Center and still holds
that position. In 2007, he was appointed Director of the Baylor Research Center
and in 2010, Program Director of the newly formed Dermatology Residency Program
at Baylor University Medical Center.
psoriatic disease research. In 1994, he co-authored the first gene discovery
for psoriasis, published in Science in 1994. His research on psoriasis has
examined everything from ultraviolet phototherapy and biologic therapy to the mapping
of genetic patterns to predict if a person is at risk of developing psoriasis
pharmacogenomics. In August 2004, Dr Menter helped found the International
Psoriasis Council to raise international awareness of psoriasis as a serious
autoimmune disease that can significantly impact quality of life. His clinical
practice includes more than 1600 patients on systemic and biologic therapy.Dr Menter held the position of clinical director of the
National Psoriasis Foundation Gene Bank from 1996 to 2002. His resume lists
some 300+ articles, four books and 19 book chapters. He serves as a member of
the editorial board for several medical journals, including the Journal of
Clinical Dermatology and Clinical and Experimental Dermatology. He is chair of research
for Dermatology at Baylor Research Institute, as well as clinical professor of
dermatology at the University of Texas Southwestern Medical School in Dallas
and professor at Texas A&M Health Science Center, College of Medicine. Dr
Menter has been listed in the Best Doctors in America since 1994 and Whös Who
in Medicine and Healthcare since 1996. He also represented the South African
National Rugby team, the Springboks, in 1968. In 2013, Dr Menter received the
Lifetime Achievement Award from the National Psoriasis Foundation. In March
2015, he received the Dermatology Foundation annual Clark W. Finnerud award at
the American Academy of Dermatology 2015 meeting in San Francisco.
Concise pocket book designed to support physicians, rheumatologists, and dermatologists in their day-to-day practice
Written by leading thought leaders and developed using the latest clinical evidence and guidelines
High quality full-color supportive illustrations, tables, and graphs enable complicated concepts to be made clear to readers with different levels of background understanding
Includes supplementary material: [...]
| Erscheinungsjahr: | 2016 |
|---|---|
| Fachbereich: | Andere Fachgebiete |
| Genre: | Medizin |
| Rubrik: | Wissenschaften |
| Medium: | Taschenbuch |
| Seiten: | 128 |
| Inhalt: |
xi
116 S. 3 s/w Illustr. 7 farbige Illustr. 7 s/w Tab. 7 farbige Tab. 116 p. 10 illus. 7 illus. in color. |
| ISBN-13: | 9783319182261 |
| ISBN-10: | 3319182269 |
| Sprache: | Englisch |
| Herstellernummer: | 978-3-319-18226-1 |
| Ausstattung / Beilage: | Paperback |
| Einband: | Kartoniert / Broschiert |
| Redaktion: |
Menter, Alan
Warren, Richard |
| Herausgeber: | Richard Warren/Alan Menter |
| Auflage: | 1st ed. 2016 |
| Hersteller: |
Springer International Publishing
Springer International Publishing AG |
| Maße: | 203 x 127 x 8 mm |
| Von/Mit: | Alan Menter (u. a.) |
| Erscheinungsdatum: | 29.01.2016 |
| Gewicht: | 0,147 kg |
Ähnliche Produkte
Lieferzeit 2-3 Wochen
Lieferzeit 2-3 Wochen
Lieferzeit 2-3 Wochen
Lieferzeit 2-3 Wochen
